An actual market study Of FESTEL CAPITAL shows that the impact of biotechnology on industrial production processes in the chemical industry will further increase. Of special interest is the production of fine chemicals, in particular of enantiomerically pure active ingredients for the agro- and pharmaceutical industry. The production costs are the decisive driving force for a change to biotechnological production processes. The goals are set towards simplifying processes and savings regarding raw materials and waste products. Apart from production costs, other factors generally do not play an important role in the choice of the production process. However, an important aspect is the accessibility of new biotech products that can not be produced by conventional processes.